Search

Once upon a time, there were great businesses with massive central labs that did both product development and basic research. Today, most corporate labs have refocused on applied research. They do not know what they are missing.

Acquisition gives Roche access to antibody-boosting technology - and possible anti-cancer treatments in the pipeline

How a Swiss university spin-off got to exit in six years - Interview with Joël Jean-Mairet, Chief Executive Officer and Joint Founder, GlycArt.

By mixing academic research with commercial ventures, Sir Richard Friend has returned to the scientific traditions of Faraday and Kelvin. He has also created a new role model for the modern scientist.